Newsletter - May17 - 03
If you are having trouble viewing this e-mail, please click here.
 
 
 
 
May 2017
 
 
Top Articles
 
 
Cracking Cancer’s Code
 
We Sit Down with George Calin of MD Anderson Cancer Center and discuss translational success, handling rejection, producing a catalog of human ncRNAs, and more…
 
 
 
 
Here Be Dragons
 
Exploring the dirty mouths of Komodo dragons may aid in the quest to tackle the issue of antimicrobial resistance. Could their blood be a source of pharmaceutical agents?
 
 
 
 
PCR out of Left Field
 
Performing PCR can be tricky in less than perfect environmental conditions. A handheld device utilizing left-handed DNA could help to make PCR more accessible, and reliable.
 
 
 
 
 
Do you have a strongly held view or key idea you want to share? Our ‘In My View’ section features focused, personal, and passionate articles about important topics in translational medicine, and you can join the conversation by contacting edit@thetranslationalscientist.com to share your viewpoint.
 
 
 
 
 
Awards
 
 
Humanity in Science Award 2017
 
Calling all philanthropic scientists – nominations for the 2017 Humanity in Science Award are now open. The award – and prize money of $25,000 – will be presented to recognize a recent scientific breakthrough that can have a positive impact on people’s lives worldwide. The 2016 award recognized the "Development of a new paper and flexible material-based diagnostic biosensing platform that could be used to remotely detect and determine treatment options for HIV, E. coli, Staphylococcus aureus and other bacteria." Could the 2017 winner be you or someone you know?
Full details and conditions available.

Nominations close June 16th.
 
 
 
 
Solutions
 
 
See how droplets are guiding precision medicine
 
Do you have the tools you need to support clinicians at decisive moments? Liquid biopsy promises a new level of precision in disease profiling and drug resistance monitoring. See how a promising new technology lets you use this method to its fullest potential to give clinicians insights that can guide personalized cancer treatments and save lives. This video featuring doctors and researchers at ONJCC outlines the adoption and clinical utility of Droplet Digital PCR.